Omid Veiseh | |
---|---|
Academic background | |
Education | BS, Western Washington University PhD, Materials Science and Engineering and Nanotechnology, 2009, University of Washington, PostDoc, MIT |
Academic work | |
Institutions | Rice University |
Website | veisehlab |
Omid Veiseh is an American biomaterials researcher and entrepreneur. As a postdoctorate candidate at MIT,he co-founded Siglion Therapeutics,a biotechnology company which would commercialize the discoveries he and his co-founders developed. In 2016,Veiseh was offered a faculty position in the Department of Bioengineering at Rice University.
Veiseh earned his Bachelor of Science degree from Western Washington University and his PhD from the University of Washington. [1] Upon completing his PhD,Veiseh completed his post-doctoral research at MIT's Koch Institute for Integrative Cancer Research where he co-developed a way to reduce immune-system rejection using biomedical devices. [2] While at MIT,he co-founded Sigilon Therapeutics,a biotechnology company which would commercialize the discoveries he and his co-founders developed. [3]
Veiseh left MIT in 2016,after Rice University won a $2 million grant from the Cancer Prevention and Research Institute of Texas to recruit him to their Department of Bioengineering. [4] As an assistant professor of bioengineering,Veiseh and his laboratory earned funding from the National Institutes of Health to design hydrogel-encapsulated cells can sense blood glucose levels and produce insulin on demand. [5] He also collaborated with Jordan Miller to combine cell-based therapy applications with 3D-printed technologies for use in Type-1 diabetes therapies. [3]
While at Rice,Veiseh's Sigilon Therapeutics partnered with Eli Lilly and Company to develop "living drug factories" that could be safely implanted in the body and produce insulin. [6] As a result of his efforts,Veiseh was recognized by MedTech Boston on their 40 under 40 Healthcare Innovators in 2017. [7] Individually,he also worked alongside Ravi Ghanta to develop a novel biomaterial improve the cells’ability to heal heart injuries. [8]
Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare purposes. BME is also traditionally logical sciences to advance health care treatment,including diagnosis,monitoring,and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement,routine testing,preventive maintenance,and making equipment recommendations,a role also known as a Biomedical Equipment Technician (BMET) or as clinical engineering.
Whitehead Institute for Biomedical Research is a non-profit research institute located in Cambridge,Massachusetts,United States that is dedicated to improving human health through basic biomedical research. It was founded as a fiscally independent entity from the Massachusetts Institute of Technology (MIT),where its 18 members all hold faculty appointments in the MIT Department of Biology or the MIT Department of Bioengineering. Two members are National Medal of Science recipients;ten have been elected to the National Academy of Sciences;and four have been elected to the National Academy of Medicine;six are Howard Hughes Medical Institute Investigators.
Andrew (Drew) David Endy is a synthetic biologist and tenured associate professor of bioengineering at Stanford University,California.
Robert Samuel Langer Jr. FREng is an American chemical engineer,scientist,entrepreneur,inventor and one of the twelve Institute Professors at the Massachusetts Institute of Technology.
Carolyn Ruth Bertozzi is an American chemist and Nobel laureate,known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they impact diseases such as cancer,inflammation,and viral infections like COVID-19. At Stanford University,she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former Director of the Molecular Foundry,a nanoscience research center at Lawrence Berkeley National Laboratory.
Peter W. Zandstra,is a Canadian scientist who is the Director of the Michael Smith Laboratories at the University of British Columbia.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering,drug delivery,bionanotechnology,pharmaceutical sciences,chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale,macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
Harvey Franklin Lodish is a molecular and cell biologist,professor at the Massachusetts Institute of Technology (MIT),Founding Member of the Whitehead Institute for Biomedical Research,and lead author of the textbook Molecular Cell Biology. Lodish's research focused on cell surface proteins and other important areas at the interface between molecular cell biology and medicine.
Jindřich Henry Kopeček was born in Strakonice,Czech Republic,as the son of Jan and Herta Zita (Krombholz) Kopeček. He is distinguished professor of pharmaceutical chemistry and distinguished professor of biomedical engineering at the University of Utah in Salt Lake City,Utah. Kopeček is also an honorary professor at Sichuan University in Chengdu,China. His research focuses on biorecognition of macromolecules,bioconjugate chemistry,drug delivery systems,self-assembled biomaterials,and drug-free macromolecular therapeutics.
Donald E. Ingber is an American cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University,the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital,and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He is also a member of the American Institute for Medical and Biological Engineering,the National Academy of Engineering,the National Academy of Medicine,the National Academy of Inventors,and the American Academy of Arts and Sciences.
Samir Mitragotri is an Indian American professor at Harvard University,an inventor,an entrepreneur,and a researcher in the fields of drug delivery and biomaterials. He is currently the Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard John A. Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering. Prior to 2017,he was the Duncan and Suzanne Mellichamp Chair Professor at University of California,Santa Barbara.
Buddy Ratner is an American professor of chemical engineering and bioengineering. He is the director of the Research Center for Biomaterials at the University of Washington. He is also the faculty member for the Program for Technology Commercialization at the University of Washington.
Edward Wilson Merrill was an American biomaterials scientist. He was one of the founders of bioengineering,and specifically the biomedical engineering field it developed from chemical engineering. Merrill was born to Edward Clifton Merrill (1881–1949),a chemical engineer and chief chemist of the United Drug Company (Rexall) and Gertrude Wilson (1895–1978).
Treena Livingston Arinzeh is Professor of Biomedical Engineering at New Jersey Institute of Technology in Newark,New Jersey. She is known for her research on adult stem-cell therapy. Arinzeh takes part in the American Chemical Society's Project Seeds program,opening up her lab for high school students from economically disadvantaged backgrounds for summer internships.
Hanmi Pharmaceutical is a South Korean pharmaceutical company that is headquartered in Seoul.
Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials,drug delivery,and tissue engineering.
Derrick J. Rossi,is a Canadian stem cell biologist and entrepreneur. He is a co-founder of the biotechnology company Moderna.
Susmita Bose is an Indian-American scientist and engineer,best known for her research on biomaterials,3D printing or additive manufacturing of bone implants and natural medicine. She is the Herman and Brita Lindholm Endowed Chair Professor in the School of Mechanical and Materials Engineering at Washington State University.
Jennifer L. West is an American bioengineer. She is the current Dean of Engineering and Applied Science at the University of Virginia. She was the Fitzpatrick University Professor of Biomedical Engineering at Duke University from 2012-2021. In 2000,West cofounded Nanospectra Biosciences in Houston to develop a cancer therapy based on gold nanoparticles that destroy tumor cells and has been listed by MIT Technology Review as one of the 100 most innovative young scientists and engineers world wide.
The Wyss Institute for Biologically Inspired Engineering is a cross-disciplinary research institute at Harvard University focused on bridging the gap between academia and industry by drawing inspiration from nature's design principles to solve challenges in health care and the environment. It is focused on the field of biologically inspired engineering to be distinct from bioengineering and biomedical engineering. The institute also has a focus on applications,intellectual property generation,and commercialization. The Wyss Institute is located in Boston’s Longwood Medical Area and has 375 full-time staff. The Wyss is organized around eight focus areas,each of which integrate faculty,postdocs,fellows,and staff scientists. The focus areas are bioinspired therapeutics &diagnostics,diagnostics accelerator,immuno-materials,living cellular devices,molecular robotics,3D organ engineering,predictive bioanalytics and synthetic biology.
Omid Veiseh publications indexed by Google Scholar